Concepedia

Chao‐Sheng Lo

CL

Statistics

Publications

25

Citations

994

H-Index

18

Active since

1970

Affiliations

Centre Hospitalier de l’Université de Montréal(Current)

Massachusetts General Hospital

Hôpital Maisonneuve-Rosemont

Université de Montréal

Harvard University

Chao‐Sheng Lo is an author at Centre Hospitalier de l’Université de Montréal specializing in renal disease, renal pathophysiology, and medicine.

ORCID

Publications per year

1970–2023

25

Publications

25

Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice

Shuiling Zhao, Anindya Ghosh, Chao‐Sheng Lo et al. · Endocrinology · 2017 · 116 citations · Full text

, , +16

Angiotensin-(1–7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice

Yixuan Shi, Chao‐Sheng Lo, Ranjit S. Padda et al. · Clinical Science · 2014 · 95 citations

, , +17

Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?

Ranjit Singh Padda Yixuan Shi, Chao‐Sheng Lo · Journal of Diabetes & Metabolism · 2015 · 75 citations · Full text

, , +9

Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice

Kana N. Miyata, Chao‐Sheng Lo, Shuiling Zhao et al. · Clinical Science · 2021 · 65 citations · Full text

, , +17

Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice

Chao‐Sheng Lo, Fang Liu, Yixuan Shi et al. · American Journal of Physiology-Renal Physiology · 2011 · 63 citations

, , +16

1–5 of 25